Cointime

Decibel Therapeutics

company

About

Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.

  • 51 - 100

Highlights

Total Funding Amount
$55M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series C
Last Funding Money Raised
$55M
Industries
Biotechnology,Medical Device,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
51 - 100
Operating Status
Active

Decibel Therapeutics is a developer of hearing disorder therapeutics intended to protect, repair and restore hearing. The company's therapeutics have provided insights into the link between hearing dysfunction and inner ear pathology and it has capabilities to encompass animal models, drug delivery to the inner ear, imaging, inner ear PK/PD modeling and measurement, bioinformatics, genetics and target identification, enabling patients to experience hearing loss therapies with different forms of hearing disorders for their recovery.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$55M
Decibel Therapeutics has raised a total of $55M in funding over 2 rounds. Their latest funding was raised on Jun 19, 2018 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 19, 2018 Series C $55M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Decibel Therapeutics is funded by 1 investors. Regeneron are the most recent investors.
Investor Name Lead Investor Funding Round
Regeneron — Series C
Cointime
Content
Company